CME Group Inc. (CME) Stock Forecast
Data as of Oct 31, 2026Financial Services · Current price $303.75 (+2.49%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 5, 2026 | Ashish Sabadra | RBC Capital | $302.00 | -0.6% |
| Feb 5, 2026 | Benjamin Budish | Barclays | $312.00 | +2.7% |
| Dec 22, 2025 | Michael Cyprys | Morgan Stanley | $320.00 | +5.3% |
| Oct 23, 2025 | Michael Cyprys | Morgan Stanley | $314.00 | +3.4% |
| Oct 23, 2025 | Alex Kramm | UBS | $280.00 | -7.8% |
| Oct 13, 2025 | Patrick O'Shaughnessy | Raymond James | $307.00 | +1.1% |
| Sep 8, 2025 | Alex Kramm | UBS | $285.00 | -6.2% |
| Jul 24, 2025 | Benjamin Budish | Barclays | $298.00 | -1.9% |
| Mar 10, 2025 | Patrick O'Shaughnessy | Raymond James | $287.00 | -5.5% |
| Oct 24, 2024 | Owen Lau | Oppenheimer | $258.00 | -15.1% |
| Oct 24, 2024 | Benjamin Budish | Barclays | $231.00 | -24.0% |
| Oct 3, 2024 | Christopher Allen | Citigroup | $250.00 | -17.7% |
| Sep 26, 2024 | Ashish Sabadra | RBC Capital | $235.00 | -22.6% |
| Sep 3, 2024 | Craig Siegenthaler | Bank of America Securities | $177.00 | -41.7% |
| Jul 25, 2024 | Brian Bedell | Deutsche Bank | $193.00 | -36.5% |
| Jul 25, 2024 | Patrick Moley | Piper Sandler | $225.00 | -25.9% |
| Jul 25, 2024 | Benjamin Budish | Barclays | $209.00 | -31.2% |
| Jun 5, 2024 | Alex Kromm | UBS | $250.00 | -17.7% |
| Apr 25, 2024 | Andrew Bond | Rosenblatt Securities | $187.00 | -38.4% |
| Apr 25, 2024 | Benjamin Budish | Barclays | $228.00 | -24.9% |
Top Analysts Covering CME
CME vs Sector & Market
| Metric | CME | Financial Services Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.44 | 2.51 | 2.41 |
| Analyst Count | 27 | 9 | 19 |
| Target Upside | +5.9% | +132.9% | +21.5% |
| P/E Ratio | 25.92 | -4.35 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $6.91B | $7.04B | $7.16B | 10 |
| 2027-12-31 | $6.98B | $7.37B | $7.76B | 11 |
| 2028-03-31 | $2.00B | $2.06B | $2.13B | 2 |
| 2028-06-30 | $1.97B | $2.03B | $2.10B | 5 |
| 2028-09-30 | $1.94B | $2.00B | $2.06B | 4 |
| 2028-12-31 | $7.81B | $7.81B | $7.81B | 8 |
| 2029-03-31 | $1.97B | $2.06B | $2.14B | 5 |
| 2029-06-30 | $1.95B | $2.03B | $2.11B | 3 |
| 2029-09-30 | $1.92B | $2.00B | $2.08B | 3 |
| 2029-12-31 | $1.89B | $1.97B | $2.05B | 3 |
| 2030-03-31 | $2.06B | $2.15B | $2.23B | 3 |
| 2030-06-30 | $2.03B | $2.12B | $2.20B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $11.80 | $12.23 | $12.96 | 8 |
| 2027-12-31 | $11.99 | $12.89 | $13.43 | 9 |
| 2028-03-31 | $3.56 | $3.72 | $3.87 | 4 |
| 2028-06-30 | $3.52 | $3.67 | $3.82 | 4 |
| 2028-09-30 | $3.45 | $3.60 | $3.75 | 6 |
| 2028-12-31 | $13.18 | $13.74 | $14.07 | 3 |
| 2029-03-31 | $3.52 | $3.72 | $3.90 | 3 |
| 2029-06-30 | $3.47 | $3.67 | $3.85 | 3 |
| 2029-09-30 | $3.40 | $3.60 | $3.77 | 6 |
| 2029-12-31 | $3.27 | $3.46 | $3.63 | 3 |
| 2030-03-31 | $3.45 | $3.65 | $3.83 | 3 |
| 2030-06-30 | $3.38 | $3.58 | $3.75 | 4 |
Frequently Asked Questions
What is the analyst consensus for CME?
The consensus among 27 analysts covering CME Group Inc. (CME) is Buy with an average price target of $299.00.
What is the highest price target for CME?
The highest price target for CME is $320.00, set by Michael Cyprys at Morgan Stanley on 2025-12-22.
What is the lowest price target for CME?
The lowest price target for CME is $151.00, set by Kenneth Hill at Loop Capital Markets on 2021-04-29.
How many analysts cover CME?
27 analysts have issued ratings for CME Group Inc. in the past 12 months.
Is CME a buy or sell right now?
Based on 27 analyst ratings, CME has a consensus rating of Buy (2.44/5) with a +5.9% upside to the consensus target of $299.00.
What are the earnings estimates for CME?
Analysts estimate CME will report EPS of $12.23 for the period ending 2026-12-31, with revenue estimated at $7.04B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.